ExploreWatchlistsPricing
  1. JP-listed companies
  2. Fuso Pharmaceutical Industries,Ltd.
  3. Financials
  4. Revenue growth (%)

Fuso Pharmaceutical Industries,Ltd. (4538)

Market cap
¥21.8B
P/E ratio
8.6x
Fuso Pharmaceutical Industries manufactures injectable medicines like intravenous solutions and kidney dialysis products, while also operating real estate leasing.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndRevenue growth (%) YoY (%)
Mar 31, 20259.3+8.13%
Mar 31, 20248.6+208.60%
Mar 31, 20232.8+262.34%
Mar 31, 20220.8-84.63%
Mar 31, 20215+178.33%
Mar 31, 20201.8+373.68%
Mar 31, 20190.4-120.11%
Mar 31, 2018-1.9-184.00%
Mar 31, 20172.3-182.12%
Mar 31, 2016-2.7-34.61%
Mar 31, 2015-4.2-495.28%
Mar 31, 20141.1-88.97%
Mar 31, 20139.6

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat